Global pharmaceutical manufacturer in reproductive medicine and hyaluronic acid therapeutics
IBSA Group is a Swiss pharmaceutical manufacturer with 2,500+ employees across 20 subsidiaries and manufacturing sites in Europe, China, and the USA. The company relies on legacy enterprise systems (SAP S/4HANA, ServiceNow) while actively scaling compliance-heavy initiatives—GMP environment IT implementations, 21 CFR Part 11 software validation, and quality system rollouts across branches—a pattern indicating significant investment in manufacturing digital transformation and regulatory infrastructure.
IBSA Institut Biochimique SA is a privately held Swiss pharmaceutical company founded in 1945 and present in over 90 countries across 5 continents. The company operates across 10 therapeutic areas, with particular strength in Reproductive Medicine (top-four global operator) and hyaluronic acid-based products. Its product portfolio spans endocrinology, pain and inflammation, dermatology, cardiometabolic, respiratory, and consumer health applications. Current hiring focus spans engineering, operations, quality, manufacturing, research, and data roles, predominantly at mid-level seniority, with all active recruitment taking place in Switzerland.
IBSA is a Swiss pharmaceutical manufacturer with 2,500+ employees, operating across 10 therapeutic areas including Reproductive Medicine, dermatology, endocrinology, and respiratory treatments. It is one of the four largest global operators in Reproductive Medicine.
IBSA has operations across over 90 countries on 5 continents, with 20 subsidiaries in Europe, China, and the USA, plus headquarters and manufacturing sites in Switzerland.
IBSA uses SAP S/4HANA for enterprise resource planning, ServiceNow for IT operations, OneTrust for compliance, DocuSign for document management, and specialized tools like Chromeleon for lab analysis and SDS-PAGE for protein analysis.
Other companies in the same industry, closest in size